78 related articles for article (PubMed ID: 12667397)
1. Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells.
Yu D; Wang Z; Zhu L; Chew EC
Chin Med J (Engl); 2003 Jan; 116(1):93-8. PubMed ID: 12667397
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of arsenic trioxide-induced apoptosis in hepatic blastoma cells HepG2].
Yu D; Wang ZH; Zhu LY
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):120-3. PubMed ID: 12795834
[TBL] [Abstract][Full Text] [Related]
3. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
Lallemand-Breitenbach V; Zhu J; Puvion F; Koken M; Honoré N; Doubeikovsky A; Duprez E; Pandolfi PP; Puvion E; Freemont P; de Thé H
J Exp Med; 2001 Jun; 193(12):1361-71. PubMed ID: 11413191
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.
Hayakawa F; Privalsky ML
Cancer Cell; 2004 Apr; 5(4):389-401. PubMed ID: 15093545
[TBL] [Abstract][Full Text] [Related]
6. Alteration of nuclear matrix protein composition of neuroblastoma cells after arsenic trioxide treatment.
Wang ZH; Yu D; Li HK; Chow VW; Ng CC; Chan HB; Cheng SB; Chew EC
Anticancer Res; 2001; 21(1A):493-8. PubMed ID: 11299786
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
8. [Effects of arsenic trioxide on the subcellular localization of PML/PML-RARalpha protein in leukemic cells].
Ni J; Chen G; Zhu J; Zhong H; Tang W; Li X; Xiong S; Shen Z; Chen S; Wang Z; Chen L
Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):32-4. PubMed ID: 15622748
[TBL] [Abstract][Full Text] [Related]
9. Death by arsenic: implications of PML sumoylation.
Mann KK; Miller WH
Cancer Cell; 2004 Apr; 5(4):307-9. PubMed ID: 15093537
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.
Gu C; Yokota N; Gao Y; Amano S; Koizumi S; Tokuyama T; Namba H
Neurol Med Chir (Tokyo); 2012; 52(2):62-7. PubMed ID: 22362285
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
Zhang X; Yang XR; Sun C; Hu B; Sun YF; Huang XW; Wang Z; He YF; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J
Cancer Lett; 2015 Sep; 366(1):112-22. PubMed ID: 26118777
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of nuclear matrix proteins in etoposide induced apoptosis in HL-60 cells.
Jin ML; Zhang P; Ding MX; Yun JP; Chen PF; Chen YH; Chew YQ
Cell Res; 2001 Jun; 11(2):125-34. PubMed ID: 11453544
[TBL] [Abstract][Full Text] [Related]
13. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
14. The effect of arsenic trioxide on the expression of Hsc and HNF4 in nuclear matrix proteins in HepG2 cells.
Yu D; Wang ZH; Cheng SB; Li HK; Chan HB; Chew EC
Anticancer Res; 2001; 21(4A):2553-9. PubMed ID: 11724321
[TBL] [Abstract][Full Text] [Related]
15. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
Chen GQ; Zhou L; Styblo M; Walton F; Jing Y; Weinberg R; Chen Z; Waxman S
Cancer Res; 2003 Apr; 63(8):1853-9. PubMed ID: 12702573
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
[TBL] [Abstract][Full Text] [Related]
17. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
Ikeda T; Kimura F; Nakata Y; Sato K; Ogura K; Motoyoshi K; Sporn M; Kufe D
Cell Death Differ; 2005 May; 12(5):523-31. PubMed ID: 15746941
[TBL] [Abstract][Full Text] [Related]
18. ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.
Joe Y; Jeong JH; Yang S; Kang H; Motoyama N; Pandolfi PP; Chung JH; Kim MK
J Biol Chem; 2006 Sep; 281(39):28764-71. PubMed ID: 16891316
[TBL] [Abstract][Full Text] [Related]
19. Effects of red orpiment on cell morphology and expression of PML mRNA and protein in NB4 and HL-60 cells.
Zhong L; Chen F; Han J; Shao N; Ouyang R
Chin Med J (Engl); 2003 Jan; 116(1):148-50. PubMed ID: 12667410
[TBL] [Abstract][Full Text] [Related]
20. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization.
Kurki S; Latonen L; Laiho M
J Cell Sci; 2003 Oct; 116(Pt 19):3917-25. PubMed ID: 12915590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
